XARACOLL: payments to doctors
Payments that named XARACOLL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $316K
- Providers
- 2,592
- Transactions
- 4,104
- Average per transaction
- $77
The per-transaction average — $77 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,592 providers the average total is $122, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Innocoll Incorporated | $181,856 | 57.5% |
| Innocoll Pharmaceuticals Limited | $126,719 | 40.0% |
| Mallinckrodt Hospital Products Inc. | $7,876 | 2.5% |